SYNERFUSE

synerfuse-logo

SynerFuse is a provider of traditional spine implants intended to offer long-term pain management without the use of addictive opioids. The company's technologies synergistically fuse with traditional spine implants to offer a more efficient and effective solution to long-term pain following back surgery, enabling physicians to improve spine implant outcomes with a drug-free pain management system. SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attac... k the problem of long-term post-surgery lower-back pain, with a preemptive, drug-free pain management system. It’s simple and brilliant. The company makes traditional spine implants more successful and cost-effective by embedding active neuromodulation therapy at the time surgeons are performing fusion back surgery. SynerFuse was founded in 2015 and is headquartered in Minneapolis, Minnesota, United States.

#SimilarOrganizations #People #Website #More

SYNERFUSE

Social Links:

Industry:
Biotechnology Medical Medical Device Therapeutics

Founded:
2015-01-01

Address:
Minneapolis, Minnesota, United States

Country:
United States

Website Url:
http://www.synerfuse.com

Total Employee:
1+

Status:
Active

Contact:
612-217-2914

Email Addresses:
info@synerfuse.com

Total Funding:
7.07 M USD

Technology used in webpage:
Domain Not Resolving COVID-19 Squarespace Hosted


Similar Organizations

agenus-logo

Agenus

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.


Current Advisors List

brian-highley_image

Brian Highley Board Director @ SynerFuse
Board_member
2021-01-01

Current Employees Featured

gregory-f-molnar_image

Gregory F. Molnar
Gregory F. Molnar Co-Founder, Chief Science Officer, Vice President, and Vice Chair @ SynerFuse
Co-Founder, Chief Science Officer, Vice President, and Vice Chair
2018-01-01

justin-zenanko_image

Justin Zenanko
Justin Zenanko Co-Founder, President and CEO, Chair of the Board of Directors @ SynerFuse
Co-Founder, President and CEO, Chair of the Board of Directors
2023-01-01

susan-alpert_image

Susan Alpert
Susan Alpert Chief Medical Officer and Chief Regulatory Officer @ SynerFuse
Chief Medical Officer and Chief Regulatory Officer

lynn-blake_image

Lynn Blake
Lynn Blake CFO @ SynerFuse
CFO

dennis-mcfadden_image

Dennis McFadden
Dennis McFadden Chief Financial Officer @ SynerFuse
Chief Financial Officer

Founder


gregory-f-molnar_image

Gregory F. Molnar

justin-zenanko_image

Justin Zenanko

Official Site Inspections

http://www.synerfuse.com Semrush global rank: 11.52 M Semrush visits lastest month: 156

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "SynerFuse"

Synerfuse | Integrated Solution to Chronic Back Pain

SynerFuse™ is a Minnesota-based medical device company innovating the spine industry with its integrated approach to spinal fusion and chronic pain. The patented SynerFuse™ procedure, …See details»

About — Synerfuse | Integrated Solution to Chronic …

SynerFuse™ was founded in 2018 with this vision. Subsequently, the company identified an enormous whitespace opportunity and built a deep and broad intellectual property portfolio around it, creating the SynerFuse™ solution of …See details»

SynerFuse - Crunchbase Company Profile & Funding

SynerFuse is a provider of traditional spine implants intended to offer long-term pain management without the use of addictive opioids. The company's technologies synergistically fuse with …See details»

Team — Synerfuse | Integrated Solution to Chronic …

Mr. Miel comes to SynerFuse with 30 years of experience in team management, organizational management, technical leadership, program management and project management utilizing classic and agile methodologies, international …See details»

SynerFuse 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for SynerFuse. Use the PitchBook Platform to explore the full profile.See details»

SynerFuse™ & Velentium Medical Partnering to Scale

1 day ago About SynerFuse™ SynerFuse™ is a Delaware corporation based in Minnesota—the heart of Medical Alley and the cradle of neuromodulation and medical device innovation.See details»

SynerFuse™ & Velentium Medical Partnering to Scale Integrated …

20 hours ago About SynerFuse™ SynerFuse™ is a Delaware corporation based in Minnesota—the heart of Medical Alley and the cradle of neuromodulation and medical device …See details»

SynerFuse - Funding, Financials, Valuation & Investors

SynerFuse is a provider of traditional spine implants intended to offer long-term pain management without the use of addictive opioidsSee details»

New procedure in Minnesota treating chronic pain …

Jul 3, 2023 Synerfuse, Inc. She opted for the new integrated solution developed by Minnesota-based Synerfuse and the University of Minnesota.See details»

SYNERFUSE, INC. Top 13F Holdings - WhaleWisdom.com

Detailed Profile of SYNERFUSE, INC. portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.See details»

Minneapolis med-tech firm SynerFuse targeting intractable back …

May 23, 2019 A Minneapolis med-tech company using nerve therapy to allay back pain has raised a $2.6 million financing round.See details»

Integrated Solution to Chronic Back Pain - Synerfuse

Ms. Friesema brings a blend of clinical trial, strategy, and operational expertise to her role leading SynerFuse’s clinical operations. Since 2018, as Principal of EMF Consulting LLC, she has …See details»

SynerFuse™ Announces First Patient Implanted in Integrated …

Jan 13, 2022 The SynerFuse Proof-of-Concept study involves combining spinal fusion with the implant of a neurostimulator to provide stimulation of the DRG, a key nerve structure along the …See details»

Susan Alpert - Advisor at SynerFuse | The Org

Dr. Alpert, the Principal of SFA Regulatory, LLC, is a health care industry executive with a unique background of regulatory, clinical, business, and technology experience, including a history of …See details»

SynerFuse™ Proof-of-Concept Study Completed - ABC27

Mar 3, 2025 "The SynerFuse™ proof-of-concept study demonstrated the safety and feasibility of integrating direct nerve stimulation with open lumbar or lumbosacral decompression and …See details»

SynerFuse™ Proof-of-Concept Study Completed - PR Newswire

Mar 3, 2025 Data from the SynerFuse™ proof-of-concept study will be used to support the publication of peer-reviewed journal articles and to support the company's application for …See details»

Lynn Blake - CFO @ SynerFuse - Crunchbase Person Profile

Lynn is the Chief Financial Officer of SynerFuse and Executive Vice President of State Street Global Advisors (SSGA) and CIO of Global Equity Beta Solutions. In this capacity, she …See details»

SynerFuse partners with Velentium Medical - Becker’s Spine Review

13 hours ago SynerFuse is partnering with Velentium Medical to scale the SynerFuse e-TLIF implant, according to a March 21 news release. Velentium Medical will support SynerFuse with …See details»

Innovation — Synerfuse | Integrated Solution to Chronic Back Pain

Innovation — Synerfuse | Integrated Solution to Chronic Back PainSee details»

Profile for Ainsley Shea - Facebook

SynerFuse completed enrollment for its proof-of-concept study to evaluate the e-TLIF procedure with direct ...See details»

linkstock.net © 2022. All rights reserved